Cite
HARVARD Citation
Ranger, A. et al. (n.d.). OP0040 Peripheral Blood Transcriptional Changes Elicited by Treatment of Systemic Lupus Erythematosus (SLE) Patients with Dapirolizumab Pegol (A Pegylated Anti-CD40L Fab'). Annals of the rheumatic diseases. pp. 68-69. [Online].